GlassScriptPhysician profile
Kellie Beth Vaught
NPI 1659326742
$17,336.22
in general payments reported to CMS, 2019-2025
52 companies · $3,539 in 2025
The $3,539 reported for 2025 was more than what 98% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,649 · 2022: $2,806 · 2023: $4,506 · 2024: $3,837 · 2025: $3,539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $490 · Education: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,954.07 |
| Travel and Lodging | $490.08 |
| Education | $437.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,215.86 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,585.15 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $1,298.99 | 2021-2025 | Ultomiris, Soliris |
| Pfizer INC. | $1,209.04 | 2021-2025 | |
| Ucb, INC. | $902.99 | 2021-2025 | Briviact, Nayzilam, Rystiggo |
| Teva Pharmaceuticals USA, INC. | $738.25 | 2021-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Emd Serono, INC. | $676.45 | 2022-2025 | Mavenclad |
| Biogen, INC. | $635.26 | 2021-2025 | Vumerity, Tysabri, Skyclarys |
| Janssen Pharmaceuticals, INC | $587.37 | 2021-2022 | |
| Argenx US, INC. | $558.57 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Neurelis, INC. | $523.09 | 2021-2025 | Valtoco |
| Sk Life Science, INC. | $484.45 | 2021-2025 | Xcopri |
| Lilly USA, LLC | $404.84 | 2021-2025 | Emgality, Kisunla, Amyvid |
| Neurocrine Biosciences, INC. | $337.79 | 2021-2025 | Ingrezza, Ongentys |
| Vanda Pharmaceuticals INC. | $326.54 | 2024-2025 | Ponvory |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellie Vaught listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.